Literature DB >> 21701494

Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia.

X Zhang, M Reis, R Khoriaty, Y Li, P Ouillette, J Samayoa, H Carter, R Karchin, M Li, L A Diaz, V E Velculescu, N Papadopoulos, K W Kinzler, B Vogelstein, S N Malek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701494      PMCID: PMC3523306          DOI: 10.1038/leu.2011.163

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.

Authors:  Mathew J Garnett; Sareena Rana; Hugh Paterson; David Barford; Richard Marais
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

2.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

3.  Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM).

Authors:  Hannah Carter; Josue Samayoa; Ralph H Hruban; Rachel Karchin
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

4.  Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations.

Authors:  Hannah Carter; Sining Chen; Leyla Isik; Svitlana Tyekucheva; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Rachel Karchin
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

5.  Somatic mutations affect key pathways in lung adenocarcinoma.

Authors:  Li Ding; Gad Getz; David A Wheeler; Elaine R Mardis; Michael D McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M Muzny; Margaret B Morgan; Lucinda Fulton; Robert S Fulton; Qunyuan Zhang; Michael C Wendl; Michael S Lawrence; David E Larson; Ken Chen; David J Dooling; Aniko Sabo; Alicia C Hawes; Hua Shen; Shalini N Jhangiani; Lora R Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E Scherer; Kerstin Clerc; Ginger A Metcalf; Brian Ng; Aleksandar Milosavljevic; Manuel L Gonzalez-Garay; John R Osborne; Rick Meyer; Xiaoqi Shi; Yuzhu Tang; Daniel C Koboldt; Ling Lin; Rachel Abbott; Tracie L Miner; Craig Pohl; Ginger Fewell; Carrie Haipek; Heather Schmidt; Brian H Dunford-Shore; Aldi Kraja; Seth D Crosby; Christopher S Sawyer; Tammi Vickery; Sacha Sander; Jody Robinson; Wendy Winckler; Jennifer Baldwin; Lucian R Chirieac; Amit Dutt; Tim Fennell; Megan Hanna; Bruce E Johnson; Robert C Onofrio; Roman K Thomas; Giovanni Tonon; Barbara A Weir; Xiaojun Zhao; Liuda Ziaugra; Michael C Zody; Thomas Giordano; Mark B Orringer; Jack A Roth; Margaret R Spitz; Ignacio I Wistuba; Bradley Ozenberger; Peter J Good; Andrew C Chang; David G Beer; Mark A Watson; Marc Ladanyi; Stephen Broderick; Akihiko Yoshizawa; William D Travis; William Pao; Michael A Province; George M Weinstock; Harold E Varmus; Stacey B Gabriel; Eric S Lander; Richard A Gibbs; Matthew Meyerson; Richard K Wilson
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

6.  Systematic genomic screen for tyrosine kinase mutations in CLL.

Authors:  J R Brown; R L Levine; C Thompson; G Basile; D G Gilliland; A S Freedman
Journal:  Leukemia       Date:  2008-08-28       Impact factor: 11.528

7.  The genomic landscapes of human breast and colorectal cancers.

Authors:  Laura D Wood; D Williams Parsons; Siân Jones; Jimmy Lin; Tobias Sjöblom; Rebecca J Leary; Dong Shen; Simina M Boca; Thomas Barber; Janine Ptak; Natalie Silliman; Steve Szabo; Zoltan Dezso; Vadim Ustyanksky; Tatiana Nikolskaya; Yuri Nikolsky; Rachel Karchin; Paul A Wilson; Joshua S Kaminker; Zemin Zhang; Randal Croshaw; Joseph Willis; Dawn Dawson; Michail Shipitsin; James K V Willson; Saraswati Sukumar; Kornelia Polyak; Ben Ho Park; Charit L Pethiyagoda; P V Krishna Pant; Dennis G Ballinger; Andrew B Sparks; James Hartigan; Douglas R Smith; Erick Suh; Nickolas Papadopoulos; Phillip Buckhaults; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein
Journal:  Science       Date:  2007-10-11       Impact factor: 47.728

8.  Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.

Authors:  Harith Rajagopalan; Alberto Bardelli; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer.

Authors:  Simon A Forbes; Gurpreet Tang; Nidhi Bindal; Sally Bamford; Elisabeth Dawson; Charlotte Cole; Chai Yin Kok; Mingming Jia; Rebecca Ewing; Andrew Menzies; Jon W Teague; Michael R Stratton; P Andrew Futreal
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

View more
  11 in total

Review 1.  Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.

Authors:  Adrian Wiestner
Journal:  Blood       Date:  2012-08-08       Impact factor: 22.113

2.  BRAFV600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia.

Authors:  Yo-Ting Tsai; Aparna Lakshmanan; Amy Lehman; Bonnie K Harrington; Fabienne McClanahan Lucas; Minh Tran; Ellen J Sass; Meixiao Long; Alan D Flechtner; Florinda Jaynes; Krista La Perle; Vincenzo Coppola; Gerard Lozanski; Natarajan Muthusamy; John C Byrd; Michael R Grever; David M Lucas
Journal:  Blood Adv       Date:  2017-10-30

3.  Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34.

Authors:  K Shedden; Y Li; P Ouillette; S N Malek
Journal:  Leukemia       Date:  2011-12-20       Impact factor: 11.528

4.  BRAFV600E induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation.

Authors:  Yo-Ting Tsai; Gerard Lozanski; Amy Lehman; Ellen J Sass; Erin Hertlein; Santosh B Salunke; Ching-Shih Chen; Michael R Grever; John C Byrd; David M Lucas
Journal:  Leuk Res       Date:  2015-09-05       Impact factor: 3.156

5.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

Authors:  Víctor Quesada; Laura Conde; Neus Villamor; Gonzalo R Ordóñez; Pedro Jares; Laia Bassaganyas; Andrew J Ramsay; Sílvia Beà; Magda Pinyol; Alejandra Martínez-Trillos; Mónica López-Guerra; Dolors Colomer; Alba Navarro; Tycho Baumann; Marta Aymerich; María Rozman; Julio Delgado; Eva Giné; Jesús M Hernández; Marcos González-Díaz; Diana A Puente; Gloria Velasco; José M P Freije; José M C Tubío; Romina Royo; Josep L Gelpí; Modesto Orozco; David G Pisano; Jorge Zamora; Miguel Vázquez; Alfonso Valencia; Heinz Himmelbauer; Mónica Bayés; Simon Heath; Marta Gut; Ivo Gut; Xavier Estivill; Armando López-Guillermo; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

6.  A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.

Authors:  Nisar A Amin; Erlene Seymour; Kamlai Saiya-Cork; Brian Parkin; Kerby Shedden; Sami N Malek
Journal:  Clin Cancer Res       Date:  2016-04-08       Impact factor: 12.531

Review 7.  The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.

Authors:  S N Malek
Journal:  Oncogene       Date:  2012-09-24       Impact factor: 9.867

Review 8.  Genomic approaches to chronic lymphocytic leukemia.

Authors:  Ma Reina Improgo; Jennifer R Brown
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

9.  Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.

Authors:  Peter Ouillette; Jinghui Li; Rita Shaknovich; Yifeng Li; Ari Melnick; Kerby Shedden; Sami N Malek
Journal:  Genes Chromosomes Cancer       Date:  2012-09-06       Impact factor: 5.006

10.  Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.

Authors:  Nidhi Aggarwal; Steven H Swerdlow; Lindsey M Kelly; Jennifer B Ogilvie; Mariana N Nikiforova; Malini Sathanoori; Yuri E Nikiforov
Journal:  Mod Pathol       Date:  2012-05-11       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.